Mr. Banjak joins Istari with many years’ experience in the pharmaceutical and legal industries. He previously served as the general counsel for Dova Pharmaceuticals, leading both the legal and compliance functions within the company. Mr. Banjak advised the company through a number of clinical and corporate milestones, including FDA approvals, a secondary public offering and the acquisition of Dova by Swedish Orphan Biovitrum AB. Prior to that, Mr. Banjak negotiated strategic contracts, advised on Foreign Corrupt Practices Act (FCPA) and Anti-Bribery matters, and labor issues at PRA Health Sciences. His industry experience spans global contract resource organizations, rare disease pharmaceutical companies and medical device companies.
Mr. Banjak was admitted to the Colorado state bar. He earned his JD from the University of Denver School of Law and a BA in Psychology from Franklin and Marshall College.